Does Smoking Reduce Infliximab’s Effectiveness against Crohn’s Disease?
Crohn’s disease (CD) is an idiopathic inflammatory bowel disease and has no known cure. CD symptoms are treated using an array of medicines, including biological agents such as infliximab. However, infliximab therapy is expensive; therefore, identifying variables that can help predict response to in...
Saved in:
Main Authors: | Neeraj Narula, Richard N Fedorak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2009-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2009/431349 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
by: Dustin E Loomes, et al.
Published: (2011-01-01) -
Exercise and Inflammatory Bowel Disease
by: Neeraj Narula, et al.
Published: (2008-01-01) -
Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
by: Remo Panaccione, et al.
Published: (2004-01-01) -
Infliximab for Crohn's Disease: More Questions than Answers
by: Hugh James Freeman
Published: (2001-01-01) -
Crohn's Disease Associated with Sweet's Syndrome and Sjögren's Syndrome Treated with Infliximab
by: Erina N. Foster, et al.
Published: (2005-01-01)